|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Biol Chem, Vol. 273, Issue 36, 23495-23503, September 4, 1998
From the Department of Veterans Affairs Medical Center, Departments
of The data used to support the idea that
malonyl-coenzyme A (CoA)-sensitive carnitine palmitoyltransferase
(CPT-I) is localized on the outer mitochondrial membrane are based on
harsh techniques that disrupt mitochondrial physiology. We have turned
to the use of the French press, which produces a shearing force that
denudes mitochondria of their outer membrane without the
physiologically disruptive effects characteristic of phosphate
swelling. Our results indicate that the mitoplasts contain just
15-19% of the outer membrane marker enzyme activity while retaining
85% of the total CPT activity and 50% of both CPT-I, as well as
long-chain acyl-CoA synthase activity, the latter two supposed outer
membrane enzymes. These mitoplasts were shown by electron microscopy to
have the configuration of mitochondria that merely have been divested
of their outer membranes. Carnitine-dependent fatty acid
oxidation was retained in the mitoplasts, showing that they were
physiologically intact. Moreover, protein immunoblotting analysis
showed that CPT-I, as well as the inner CPT-II, was localized in the
mitoplast fraction. The outer membrane fraction, which consisted of
membrane "ghosts," contained most (50-60%) of marker enzyme
activity, monoamine oxidase-B and porin proteins, but only about
27-29% CPT-I activity. Because CPT-I and long-chain acyl-CoA
synthetase appear to be associated with both inner and outer membranes,
we postulate that these enzymes reside in contact sites, which
represent a melding of both limiting membranes.
The two carnitine palmitoyltransferase
(CPT)1 enzyme activities are
essential in the mitochondrial oxidation of long-chain fatty acids. The
malonyl-CoA-sensitive or outer form of CPT (variously termed CPT-1,
CPT-I, CPTo, overt, or outer form) is the first committed
step in mitochondrial long-chain fatty acid oxidation. The
intramitochondrial localization of this enzyme is controversial. Murthy
and Pande (1) reported that CPT-I is present in the outer membrane and
the catalytic site is specifically localized on its inner surface,
whereas Fraser et al. (2) recently have proposed that this
site is on the outer surface. In contrast, two groups of investigators
have reported that the enzyme is localized to the outer surface of the
mitochondrial inner membrane (3-5).
Previous studies on the localization of CPT have relied upon techniques
for separating inner and outer membranes that potentially could alter
the membranes by producing breaks with subsequent annealing in a
non-native configuration and which might not yield membranes of
absolute purity. To overcome these potential pitfalls in localizing the
malonyl-CoA-sensitive CPT, we have utilized a method of mitochondrial
fractionation that does not rely on methods that use either organellar
swelling to rupture the outer membrane (1, 2), or exposure to
detergents (3), or enzymatic digestion of membrane components (5).
Instead, we have utilized physical shearing produced by the French
press to skin isolated rat liver mitochondria so that the outer
membrane can be detached and separated from the residual mitoplasts
without exposure to potentially harmful agents. We have carried out
functional and enzyme marker studies to monitor the procedure and the
separated membranes were used to determine the localization of CPT.
Moreover, we used electron microscopy to monitor the purity and
structural integrity of the various membrane fractions. Our data show
that CPT-I and long-chain acyl-CoA synthase, supposed outer membrane enzymes, are associated with a component of the mitoplast fraction.
Isolation and Purification of Mitochondria--
Livers from 4-5
rats were pooled, yielding a gross weight of 50 g for each
experiment. The livers were minced, rinsed with 220 mM
mannitol, 70 mM sucrose, 5 mM MOPS, pH 7.4 (MSM, isolation buffer) containing 2 mM EGTA and a 10%
homogenate prepared using two strokes of a Potter-Elvehjem
loose-fitting Teflon pestle. The mitochondria were isolated by
differential centrifugation, washed twice in isolation buffer, and
resuspended in 0.2 ml of isolation buffer/g of liver, yielding a
mitochondrial protein concentration of 80-100 mg/ml (6). Further
purification of mitochondria was achieved using self-forming Percoll
gradient centrifugation. One ml aliquots of mitochondrial suspensions
were layered on top of 20 ml of 30% Percoll in MSM (a total of eight tubes were prepared in this manner for each experiment) and centrifuged for 30 min with 35,000 rpm (50.2 Ti rotor, Beckman L8-M). The tubes
each contained two distinct layers separated by a clear zone. The upper
layer (which electron microscopy revealed to consist of peroxisomes)
and the clear zone were removed and the lower brownish layer consisting
of mitochondria collected. Following a 2-fold dilution with MSM, the
mitochondria were collected by centrifugation (10 min, 7000 × g) and washed once with isolation buffer. This preparation
was designated as the Percoll-purified rat liver mitochondria.
French Press Treatment of Percoll-purified Mitochondria--
The
final pellet from above was resuspended in 2× MSM containing 0.5 mg of
defatted BSA/ml and protease inhibitors (1.0 µg/ml each aprotinin,
antipain, pepsatin A, benzethonium chloride, and benzamidine, and 0.1 mM phenylmethyl sulfonium fluoride) and after 10 min was
loaded into the French press (American Instrument Co., Silver Spring,
MD) fitted with a 12-ml cell according to the directions of the
manufacturer and to the protocol of Decker and Greenawalt (7). The
mitochondria were subjected to a pressure of 2000 p.s.i. while
being extruded at a rate of 7-8 ml/min. This pressure was selected
after a series of preliminary experiments wherein the pressure was
varied from 1400 to 2600 p.s.i. (see "Results"). The material
exiting the French press was collected, diluted with 12 ml of 2× MSM
containing 0.5% BSA and protease inhibitors, and fractionated by
differential centrifugation (10 min, 12000 × g). The
pellet was washed once with 12 ml of 2× MSM by resuspension and
centrifugation as above, and the pellet, designated as the mitoplast
fraction, resuspended in 3.0 ml of MSM containing protease inhibitors.
The combined supernatant fluids were subjected to centrifugation for 30 min with 45,000 rpm (50.2 Ti rotor, Beckman L8-M) and the pellet, outer
membrane fraction, resuspended in approximately 1.0 ml final volume of
MSM. During the entire isolation procedure, the volumes of different
fractions were recorded and aliquots saved for subsequent
morphological, enzymological and balance studies.
Electron Microscopy--
An aliquot of each and every
mitochondrial fraction was added to an equal volume of
phosphate-buffered, full-strength Karnovsky's fixative (8), mixed, and
immediately spun down for 30 s in a microcentrifuge. The resultant
pellets were removed from the centrifuge tubes, and the fixation
continued in half-strength Karnovsky's fixative for a total of 2 h. The pellets were thoroughly rinsed in distilled water, then
postfixed for 2 h in an unbuffered 1:1 mixture of 2% osmium
tetroxide and 3% potassium ferricyanide (9). After rinsing with
distilled water, the specimens were soaked overnight in an acidified
solution of 0.25% uranyl acetate (10). After another rinse in
distilled water, they were dehydrated in ascending concentrations of
ethanol, passed through propylene oxide, and embedded in an
Epon-Maraglas mixture (11). Thin sections were sequentially stained
with acidified methanolic uranyl acetate (10) and lead tartrate (12)
and examined in a Zeiss CEM 902 electron microscope.
Enzyme and Protein Assays--
CPT activity was determined using
three different radiochemical assays (3). 1) Assay-forward measures the
forward reaction (palmitoyl-L-carnitine formation) in the
presence of N-ethylmaleimide to prevent the reverse
direction using solubilized mitochondrial fractions. The assay system
contained in a final volume of 250 µl: 80 mM KCl, 50 mM MOPS, 1.0 mM EDTA, 0.1% defatted BSA, 1.0 mM N-ethylmaleimide, 0.2 mM
palmitoyl-CoA, and 15 mM
L-[methyl-14C]carnitine, pH 7.0. After preincubation, the reaction was initiated with 10 µl (25 µg)
of sample solubilized with 10 mM Lubrol PX. Following a
5-min incubation at 37 °C, the reaction was terminated with 1.5 ml
of cold 1.0 N HCl and the reaction product extracted into
1.0 ml of water-saturated n-butanol. The butanol phase was washed with 2.0 ml of butanol-saturated water, and 0.4 ml of the organic phase was used to determine the formation of radioactive palmitoyl-L-carnitine (13). The CPT activity was calculated on the basis of the specific radioactivity of
L-[methyl-14C]carnitine. 2)
Assay-reverse measures the reverse reaction (palmitoyl-CoA formation)
in the presence of high
palmitoyl-L-[methyl-14C]carnitine and free
CoASH concentration. The assay system contained in a final volume of
200 µl: 80 mM KCl, 50 mM MOPS, 1.0 mM EGTA, 4.0 mM dithiothreitol (DTT), 0.1%
defatted BSA, 2.0 mM CoASH, and 2.0 mM
palmitoyl-L-[Me-14C]carnitine, pH
7.0. After preincubation, the reaction was initiated with 10 µl (25 µg) of sample. Following a 5-min incubation at 37 °C, the reaction
was stopped with 0.2 ml of cold 6% perchloric acid and the
precipitated protein and unreacted
palmitoyl-L-[methyl- 14C]carnitine
removed by centrifugation. The radiolabeled free carnitine formed
during the reaction was determined by counting 0.3-ml aliquots of the
acidic supernatant. 3) Assay-modified forward is optimized for
measuring the malonyl-CoA-sensitive CPT activity (CPT-I), and contains
in a final volume of 250 µl: 80 mM KCl, 50 mM
MOPS, 1.0 mM EGTA, 4.0 mM DTT, 2.0 mM KCN, 0.4% defatted BSA, 50 µM palmitoyl-CoA, ±200 µM malonyl-CoA, pH 7.0, and 10 µl
(25 µg) of sample. Following preincubation, the reaction was
initiated with
L-[methyl-14C]carnitine (5.0 mM final concentration). The reaction was terminated after
a 3-min incubation at 37 °C and the formation of radioactive palmitoylcarnitine determined as described above. The difference in
rate obtained in the absence and presence of malonyl-CoA represents CPT-I activity (14). Since malonyl-CoA inhibition of CPT-I is subject
to changes due to desensitization of the enzyme to the inhibitor (15,
16), the activity also was determined using the active-site directed
covalent inhibitor, etomoxiryl-CoA (17). For this, samples at 2.5 mg/ml
150 mM NaCl, 10 mM potassium phosphate, 0.1 mM EGTA, and 0.5 mM DTT were preincubated for
15 min. at room temperature with 0.5 µM etomoxiryl-CoA
and 10-µl aliquots assayed as described above for the modified
forward reaction.
Measurement of Oxidative Phosphorylation-- A Clark oxygen electrode was used to monitor oxygen uptake in 1.0 ml of incubation medium containing 80 mM KCl, 50 mM MOPS, 5.0 mM Pi, 1.0 mM EGTA, 1 mg of defatted BSA, and 1.0 mg of mitochondrial protein (24). The final pH was 7.0, and the temperature was 30 °C. Respiration was determined in the absence and presence of 3.2 µM exogenous cytochrome c by addition of substrate to the incubation medium after depletion of endogenous substrates by small amounts of ADP. The substrates tested and their respective concentrations are given in the appropriate table legend. Immunological Methods-- Beef liver mitochondrial CPT-II was purified to apparent homogeneity (data not shown) and rabbit polyclonal antibodies were raised against it using standard immunological methods. CPT-I-peptide antibodies: A synthetic peptide corresponding to the deduced N-terminal 3-17 amino acid residues (25, 26) of rat liver and heart mitochondrial CPT-I was custom synthesized with a cysteine added to provide a thiol linkage to keyhole limpet hemocyanin (KLH). The peptide was coupled to KLH using the heterobifunctional cross-linker, sulfosuccinimidyl 4-[N-maleimidomethyl]cyclohexane-1-carboxylate as recommended by the manufacturer (Pierce). The KLH-conjugated peptide (400 µg of peptide) was emulsified with Freund's complete adjuvant and injected into rabbits. Booster injections in Freund's incomplete adjuvant were given 5 and 7 weeks following immunization. For immunoblot analysis of rat liver mitochondrial subfractions, aliquots equivalent to 0.5 milliunit of CPT-I (modified forward assay) and/or total CPT activity (forward assay) were subjected to SDS-polyacrylamide gel electrophoresis according to Laemmli (27), and the separated polypeptides electroblotted to nitrocellulose membranes. The membranes were probed with rabbit polyclonal anti-beef liver mitochondrial CPT-II, rabbit polyclonal anti-CPT-I peptide, rabbit polyclonal anti-beef liver mitochondrial monoamine oxidase-B (MAO-B), and mouse monoclonal anti-human porin antibodies, respectively, and following development with alkaline phosphatase-conjugated secondary antibodies, the cross-reacting proteins were visualized using 5-bromo-4-chloro-3-indoyl phosphate and p-nitro blue tetrazolium chloride. Animals and Reagents-- Male Sprague-Dawley rats (200-400 g) were obtained from Zivic-Miller (Allison Park, PA) and had free access to food and water. Mouse monoclonal antibodies against human porin (voltage-dependent anion channel) specific for the N-terminal region were purchased from Calbiochem, and rabbit polyclonal antiserum against beef liver mitochondrial monoamine oxidase-B was kindly provided by Dr. R. McCauley, Wayne State University, Detroit, MI. L-[methyl-14C]Carnitine (28) and palmitoyl-L-[methyl-14C]carnitine (29) were synthesized as referenced. Etomoxiryl-CoA was synthesized by the mixed anhydride method as described for the synthesis of long-chain acyl-CoA esters (30). All other chemicals were of the highest purity commercially available.
Mitochondria isolated in our usual way (6) showed normal state 3 and 4 respiratory rates, respiratory control ratios (RCR) of 5.2 ± 0.6, and normal ADP/O ratios, indicating the high degree of inner membrane integrity. This sample was the starting material for our French press experiments. As a first approximation, we used the pressure found by Decker and Greenawalt (7) to be best for separating inner and outer membranes, i.e. 1500 p.s.i. Unlike Decker and Greenawalt, who at a pressure of 1500 p.s.i. found that only 5% of the outer membrane marker enzyme, monoamine oxidase, was retained by the mitoplasts, we found with our French press 80% of the enzyme remained associated with the mitoplasts at this pressure (Fig. 1). The discrepancy between our results and those of Decker and Greenawalt might be due to a difference in the size of the pressure cell used in the respective experiments.
In an effort to increase the degree of detachment of the outer membrane from mitoplasts so that these two components could be cleanly separated, we carried out a systematic study varying the pressure in our French press (Fig. 1). To judge the efficacy of a particular pressure, we measured the monoamine oxidase activity of the putative mitoplasts. Proceeding from 1500 to 2200 p.s.i., there was a progressive decrease in the recovery of monoamine oxidase activity associated with the mitoplast fraction (Fig. 1) from 80% of the beginning total mitochondrial activity to 20% at 2000 p.s.i. There is no change between 2000 and 2200 p.s.i.; above 2200 p.s.i., mitoplast damage increases. In addition to studies of the recovery of monoamine oxidase, parallel studies of oxidative phosphorylation were carried out on the mitoplasts resulting from the different pressures. Glutamate oxidation was 50% of the beginning mitochondrial activity in mitoplasts prepared at 2000 p.s.i. while the RCR was 2.6 ± 0.1 and the ADP/O ratio was 2.38 ± 0.20, showing retention of the ability to couple oxidative phosphorylation in the mitoplasts. The oxidation of palmitoylcarnitine plus L-malate, as well as palmitoyl-CoA plus L-carnitine and L-malate was 60-70% of the starting activity. Therefore, we selected 2000 p.s.i. as the optimal pressure to use in fractionating rat liver mitochondria. Percoll-purified Mitochondria-- Not only were the mitochondria used in our studies examined biochemically, but morphologically as well by electron microscopy. The starting sample consisted almost entirely of intact mitochondria with a very slight contamination by other types of organelles (Fig. 2). The mitochondria were spherical, had retained both limiting membranes, and had a relatively dense inner compartment. Most showed a modest dilatation of their cristae, but some had cristae that were identical in configuration to those in their in situ counterparts. A few bodies, presumably damaged mitochondria, had lost their outer membrane, the resultant mitoplast being swollen, cristae-free, and of relatively low density.
French Press-treated Mitochondria-- The Percoll-purified mitochondria were washed and then resuspended in hyperosmolar 2× MSM followed 10 min later by extrusion through the French press at 2000 p.s.i. After passage through the French press, the mitochondrial fraction appeared to comprise three morphologically distinct subclasses. The first consisted of structurally unaltered organelles identical to those in the untreated sample. The second consisted of mitoplasts that completely lacked any trace of outer membrane. Of these, some retained their characteristic matrix density, whereas others were rather pallid. In both cases, the cristae had kept their inward orientation, no mitoplasts exhibiting everted cristae in the manner of those illustrated by Schnaitman and Greenawalt (21). The final category of mitochondria consisted of organelles that in terms of density and of configuration of cristae resembled those in the starting mitochondria, but from which a portion of the outer membrane had been stripped. The residual outer membrane either lay flat against the inner membrane in its original position or in part formed small vesicles that seemed to adhere to the organelles. The French press-treated mitochondria were fractionated using differential centrifugation to produce a low speed mitoplast (inner membrane-matrix) preparation and a supernatant. The low speed supernatant was ultracentrifuged to produce a high speed pellet (the outer membrane fraction) and a supernatant. The biochemical data associated with the mitochondrial fractionation are shown in Table I. The specific activity of the marker enzymes is presented as well as the percentage of activity recovered in each fraction using the amount (specific activity × mg of protein) of Percoll-purified French press-treated mitochondria as 100%. The distribution of monoamine oxidase activity shows that 70% of the mitochondrial activity was released by French Press treatment, the outer membrane fraction contained 48%, and the soluble supernatant fraction contained an additional 21% of the starting activity. The recovery of monoamine oxidase activity in the mitoplasts was 19%. Since monoamine oxidase is a classical outer membrane enzyme, these data indicate that the mitoplasts retain only 19% of the outer membrane, while the remainder is released into the supernatant. An additional outer membrane marker enzyme, rotenone-insensitive NADH cytochrome c reductase (cytochrome b5, RINCR), also was determined, and the results are nearly identical to that observed with monoamine oxidase (Table I). The outer membrane vesicles isolated from this supernatant show a 38-40-fold enrichment of both monoamine oxidase and NCRRI compared with the mitoplasts (Table II).
Mitoplast Fraction-- The inner membrane-matrix fraction consisted of a mixture of mitochondria in various stages of denudation (Fig. 4), ranging from intact outer membrane (whole mitochondria), through mitoplasts with partial outer membrane, to "naked" mitoplasts (Fig. 5). In every case the cristae were inwardly directed. The matrix compartment retained its characteristic density. The retained outer membrane appeared sufficient to account for the small amount of monoamine oxidase activity (19%) present in this fraction. Strewn among the mitoplasts were some membranous vesicles of unknown provenance.
Outer Membrane Vesicles-- This fraction consisted almost wholly of a series of membrane vesicles that, in keeping with the terminology of Parsons (31), can be called "ghosts" (Figs. 6 and 7). Some of these ghosts contained entrapped small membrane vesicles. A few scattered mitoplasts in both damaged or pristine condition also were present.
Immunoblotting-- To further verify the localization of CPT enzymes, we subjected membrane fractions to SDS-polyacrylamide gel electrophoresis immunoblotting. As a yardstick, we used a polyclonal antibody against MAO-B (the predominant isoform of MAO in rat liver mitochondria) and a monoclonal antibody against porin. Using identical amounts of proteins for the respective blots, both proteins are enriched in the outer membrane fraction (Fig. 8). Because the monoclonal antibody against porin was derived from a human B cell antigen, we verified that the antibody cross-reacted with purified porin from rat liver mitochondria (lane 12, Fig. 8).
The results of our study show that CPT activity resides mainly in the mitoplast membranes and to a lesser extent in the outer membrane. This is true of total CPT, whether measured as the forward or reverse reaction. About 85% of the activity measured in either direction is present in mitoplasts, whereas less than 3% activity is present in the outer membrane fraction. Furthermore, the malonyl-CoA-sensitive activity showed a similar distribution with 52% of the activity in the mitoplasts and 29% in the outer membrane. To determine the composition of the membrane fractions, we carried out various biochemical tests. The purity and integrity of our mitoplast fraction is indicated by the fact that 91-94% of the marker enzymes for the inner membrane (cytochrome c oxidase) and matrix (citrate synthase) is retained by these structures. In addition, the capacity for coupled oxidative phosphorylation is maintained, the slightly reduced respiratory control ratios notwithstanding. Not only were these mitoplasts functionally normal, but electron microscopy showed that morphologically most of these bodies are a near simulacrum of their in situ counterparts, i.e. they have inwardly directed cristae. In contrast to mitoplasts, the outer membrane ghosts contained less that 3% of the total CPT activity whether measured in the forward or reverse direction. These ghosts retained 29% of the malonyl-CoA-sensitive CPT activity. That these ghosts actually consisted of outer membrane is shown by the almost 10-fold increase in the specific activity and 7-9-fold enrichment of monoamine oxidase and RINCR, outer membrane markers. Although a small amount of inner membrane-matrix enzymes was found in this fraction (<5%), it should be noted that electron microscopy revealed it to contain a small number of mitoplasts, enough to account for this contamination. If in fact the CPT activity is confined mainly to the mitoplast fraction, then these structures should be capable of oxidizing palmitoyl-CoA plus carnitine as well as palmitoylcarnitine. In a similar fashion, if long-chain acyl-CoA synthetase also is confined mainly to the mitoplast fraction, then palmitate oxidation by mitoplasts should be retained. It is obvious that if these key enzymes reside in and are removed with the outer membrane, then the mitoplast fraction would be incapable of carrying out those oxidations. In contrast, our mitoplast preparations retain 100% of the capacity to oxidize not only the non-lipid substrates tested, but palmitoylcarnitine and, above all, palmitoyl-CoA plus carnitine, and palmitate. If the malonyl-CoA-sensitive form of CPT had been removed from the mitoplasts, the rate for the oxidation of palmitoyl-CoA plus carnitine should have fallen virtually to zero, which it did not. Long-chain acyl-CoA synthetase and palmitate oxidation behave in a like fashion. Although as early as 1963 Fritz and Yue (32) proposed dual localization of CPT activity within mitochondria, subsequent studies could detect CPT activity only in the inner membrane (3, 5). In 1972, Hoppel and Tomec (3), using a multifaceted approach, reported that CPT activity exists in two sites associated with the inner membrane, one termed CPT-A on the outer aspect, the other termed CPT-B on the inner aspect. This interpretation was supported in a subsequent study by Fritz (5), who employed a technically different approach. That CPT was localized on the inner membrane was generally accepted until 1987, when Murthy and Pande (1) offered an alternative conclusion based on their new data. These workers suggested that the malonyl-CoA regulatory site is on the cytosolic side of the outer membrane, whereas CPT actually is on the inner surface of the outer membrane. In order to separate the membranes, these investigators used the hypotonic phosphate swelling procedure developed by Parsons et al. (31). Starting with the same swelling procedure of mitochondria, Fraser et al. (2) then studied the effect of proteolytic enzymes on the regulation of malonyl-CoA-sensitive CPT activity and concluded that both the regulatory and catalytic site of CPT-I are on the cytosolic face of the outer membrane. When we repeated the hypotonic swelling experiments, we found that the enrichment of malonyl-CoA-sensitive CPT in the outer membrane vesicles was only 20% that of monoamine oxidase, the premier marker of outer membrane (33). This lack of agreement may be explained by the fact that hypotonic phosphate treatment dislodges at least part of the CPT activity from mitochondria. Such liberated CPT conceivably could end up in an outer membrane fraction by entrapment within the membranous vesicular structures that Parsons et al. (31) found to be plentiful in this particular fraction. The history of intramitochondrial localization of enzymes is rife with examples of erroneous localizations that were based on the application of inappropriate methodologies. Not only does hypotonic swelling have its drawbacks, but most other procedures for localizing CPT have associated pitfalls. For example, digitonin not only fragments the outer membrane by complexing with its cholesterol, but it also distorts the mitoplasts (34, 35). Phospholipase C, which also has been used to fragment the outer membrane, does so by digestion of membrane phospholipids. The major problem with all three of these techniques is that the resultant mitoplasts manifest little to no respiratory control ratios, which is the hallmark of mitochondrial integrity. A decided asset in our study is the use of electron microscopy to monitor the structural integrity and purity of each and every fraction. Although such an approach was commonplace in the early days of modern cell fractionation, the advantages of this protocol have largely been lost sight of nowadays. If electron micrographs accompany recent papers, they tend to be at relatively high magnifications. Thus, they provide a highly restricted view of the organelles under study and may not be representative of the sample as a whole. To guard against sampling error, all of our samples are fixed in suspension, then pelleted. This fixation technique forestalls the stratification that occurs when organelle suspensions are first pelleted, then fixed. The pellets, which we have fixed in suspension, are subdivided, then embedded without regard to orientation. Embeddings are randomly selected for sectioning, and micrographs of random fields are taken at low magnification to obtain an overall picture of the sample under investigation. Of course, some organelles are examined at higher magnification to provide details of structure not discernible at lower power. Using these protocols, we do not have to rely solely on biochemical evidence. We have direct visualization of the phenomenon of outer membrane removal, and the electron microscopy evidence can be roughly quantitated and correlated with biochemical data. Moreover, it becomes a simple matter to determine if our samples have been contaminated with any other cellular components. As a further confirmation of our enzymic and morphological findings, we turned to immunoblotting to localize specific proteins. Although this technique is at best semi-quantitative, it provides additional information on enzyme localization. Using antibodies against MAO-B and porin, we found that these two proteins are enriched in the outer membrane fraction consistent with the localization of MAO activity. With an antibody directed against beef liver CPT-II, the inner form of CPT, the protein localized to the mitoplast fraction again consistent with the enzymic activity data. With an antibody directed against a peptide representing amino acids 3-17 of CPT-I, the bulk of the protein that was decorated is present in the mitoplast fraction. The immunologically determined distribution of the various proteins reflects the fact that CPT-I is associated not only in some fashion with the inner membrane, but that it has a relationship with the outer membrane as well. A candidate for a structure that encompasses both inner and outer mitochondrial membranes is the so-called contact sites, which are localized segments where the inner and outer membranes are fused. Various functions, such as protein translocation (36, 37) and adenine nucleotide transport (38, 39), have been ascribed to contact sites. Recently, Fraser and Zammit (40) reported that CPT-I and CPT-II proteins, identified by immunoblot analysis, had a non-uniform distribution with enrichment in the contact site fraction from rat liver mitochondria. The localization of CPT-I in contact sites offers an explanation for the discrepant results obtained by the use of different membrane isolation techniques. We propose that hypotonic swelling results in the contact sites being removed in conjunction with the outer membrane, whereas treatment with the French press results in the contact sites being retained by the mitoplasts.
* This work was supported by National Institutes of Health Grant DK-36069 and by Medical Research Service of the Department of Veterans Affairs. This work was presented at Experimental Biology 97, New Orleans, LA, April 6-9, 1997 and published in abstract form (Hoppel, C. L., Kerner, J., Turkaly, P., Turkaly, J., and Tandler, B. (1997) FASEB J. 4, A445).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Medical Research Service (151W), VA Medical Center, 10701 East Blvd., Cleveland, OH 44106. Tel.: 216-421-3221; Fax: 216-229-8509; E-mail: CLH5{at}po.cwru.edu.
The abbreviations used are: CPT, generic carnitine palmitoyltransferase; CPT-I and CPT-II, malonyl-CoA-sensitive and -insensitive carnitine palmitoyltransferase; MAO, monoamine oxidase; RINCR, rotenone-insensitive cytochrome c reductaseKLH, keyhole limpet hemocyaninBSA, bovine serum albuminDTT, dithiothreitolRCR, respiratory control ratioMOPS, 4-morpholinepropanesulfonic acid.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc. This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||